THE MEDICAL MANAGEMENT OF STROKE
暂无分享,去创建一个
[1] W. Dick,et al. Stroke--a medical emergency. , 1999, Journal of accident & emergency medicine.
[2] J. Grotta. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. , 1997, Stroke.
[3] Zheng-Ming Chen,et al. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.
[4] C. Forbes,et al. EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKE , 1997, International journal of clinical practice.
[5] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[6] P. Bell,et al. Carotid and Vertebral Artery Transluminal Angioplasty Study , 1997, The Lancet.
[7] Langhorne,et al. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke , 1997, BMJ.
[8] A. Dávalos,et al. Progression of ischaemic stroke and excitotoxic aminoacids , 1997, The Lancet.
[9] H. Diener,et al. Termination of Acute Stroke Studies Involving Selfotel Treatment , 1997, The Lancet.
[10] P. Bath. Streptokinase increased mortality in acute ischemic stroke , 1997, Evidence Based Medicine.
[11] W. Marshall,et al. Changes in Serum Lipid Measurements following Acute Ischaemic Stroke , 1997 .
[12] David Schultz,et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.
[13] P. Hamet,et al. Shanghai trial of nifedipine in the elderly , 1996 .
[14] I. Aboderin,et al. Stroke management in Europe , 1996 .
[15] G. Hankey,et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, JAMA.
[16] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.
[17] J. Slattery,et al. Blood pressure and risk of stroke in patients with cerebrovascular disease , 1996, BMJ.
[18] M. Hommel,et al. Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.
[19] W Ceusters,et al. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial , 1996, The Lancet.
[20] C. Anderson,et al. BLOOD PRESSURE LOWERING IN PATIENTS WITH CEREBROVASCULAR DISEASE: RESULTS OF THE PROGRESS (PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY) PILOT PHASE , 1996, Clinical and experimental pharmacology & physiology.
[21] P. Hamet,et al. Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.
[22] P. Bath,et al. Do Acute Stroke Units Improve Care , 1996 .
[23] P. Bath,et al. The King's College Hospital Acute Stroke Unit , 1996, Journal of the Royal College of Physicians of London.
[24] D. Kromhout. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.
[25] A. Ahuja,et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke , 1995 .
[26] S. Ebrahim,et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.
[27] A. Davies,et al. Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.
[28] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[29] P. Bath. Treating acute ischaemic stroke , 1995, BMJ.
[30] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[31] J. Grotta. Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy , 1995, Journal of internal medicine.
[32] B. Olofsson,et al. Atenolol in Secondary Prevention after Stroke , 1995 .
[33] J. Wardlaw. Is routine computed tomography in strokes unnecessary? , 1994, BMJ.
[34] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[35] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[36] M. Alberts. Tissue plasminogen activator in acute stroke. , 1993, AJNR. American journal of neuroradiology.
[37] A. Morris,et al. The experiences of an acute stroke unit--implications for multicentre acute stroke trials. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[38] I. Perry,et al. Salt intake and stroke: a possible direct effect. , 1992, Journal of human hypertension.
[39] M. Laakso,et al. The European Stroke Prevention Study , 1991, Neurology.
[40] C. Warlow,et al. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis , 1991, The Lancet.
[41] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[42] V. Hachinski,et al. THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.
[43] Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.
[44] V. Rich. Personal communication , 1989, Nature.
[45] R. Doll,et al. Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.